Search Results
1 - 12 of 22 matches
Sort by:
Phase 2 Trial of Zerlasiran: Multiple doses of an siRNA Targeting Lipoprotein(a) over 60 weeks
Presenter:
Steven E. Nissen
November 18, 2024
TCT 260: Lipoprotein (a) and Endoluminal Disease Phenotype
Presenter:
TsungYing Tsai
October 30, 2024
TCT 1019: Coronary Plaque Characteristics Assessed by Optical Coherence Tomography and Plasma Lipoprotein (a) Levels in Patients With Acute Coronary Syndrome
Presenter:
Francesca Maria Di Muro
October 29, 2024
I Measured Lipoprotein (a): What was I Thinking, and Now What Do I Do?
Presenter:
Dipti Itchhaporia
October 29, 2024
Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a)
Presenter:
Steven E. Nissen
November 11, 2023
Lipoprotein(a): Why Measure and What to Do?
Presenter:
Sotirios Tsimikas
October 26, 2023
TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).
Presenter:
Mick Renkens
October 25, 2023
Lipoprotein(a): The New Kid on the Block
Presenter:
Pam R. Taub
June 15, 2023
Reduction of Lipoprotein(a) With Small Interfering RNA: Results of the OCEAN(a)-DOSE (TIMI 67) Trial
Presenter:
Michelle L. O’Donoghue
November 7, 2022